NCT06021054 · Interventional trial
An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)
Overall registry status Completed
Phase 3
Conditions Thyroid Eye Disease
Delaware Valley sites
- Department of Ophthalmology, University of Pennsylvania · Philadelphia, PA · Philadelphia County
- Wills Eye Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory